Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Review Group ◽

Previously Treated ◽

Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective

PharmacoEconomics ◽

10.1007/s40273-015-0296-5 ◽

2015 ◽

Vol 33 (11) ◽

pp. 1187-1194 ◽

Cited By ~ 11

Author(s):

Emma L. Simpson ◽

Sarah Davis ◽

Praveen Thokala ◽

Penny R. Breeze ◽

Peter Bryden ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-021-01098-3 ◽

2021 ◽

Author(s):

Sabine E. Grimm ◽

Willem Witlox ◽

Robert Wolff ◽

Annette Chalker ◽

Mickael Hiligsmann ◽

...

Keyword(s):

Mycosis Fungoides ◽

Evidence Review Group ◽

Sézary Syndrome ◽

Sezary Syndrome ◽

Technology Appraisal ◽

Review Group ◽

Previously Treated ◽

Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal”

PharmacoEconomics ◽

10.1007/s40273-017-0507-3 ◽

2017 ◽

Vol 35 (6) ◽

pp. 665-667

Author(s):

Bram L. T. Ramaekers ◽

Rob Riemsma ◽

Florian Tomini ◽

Thea van Asselt ◽

Sohan Deshpande ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Abiraterone Acetate ◽

Technology Appraisal ◽

Castration Resistant Prostate Cancer ◽

Review Group ◽

Castration Resistant ◽

Letter To The Editor ◽

Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-016-0481-1 ◽

2016 ◽

Vol 35 (7) ◽

pp. 717-726 ◽

Cited By ~ 2

Author(s):

Lesley Uttley ◽

Sophie Whyte ◽

Timothy Gomersall ◽

Shijie Ren ◽

Ruth Wong ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0677-7 ◽

2018 ◽

Vol 36 (12) ◽

pp. 1427-1437 ◽

Cited By ~ 1

Author(s):

Iñigo Bermejo ◽

Shijie Ren ◽

Emma Simpson ◽

Mark Clowes ◽

David L. Scott ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Evidence Review Group ◽

Technology Appraisal ◽

Severe Rheumatoid Arthritis ◽

Review Group ◽

Previously Treated ◽

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-020-00971-x ◽

2020 ◽

Author(s):

Willem J. A. Witlox ◽

Sabine E. Grimm ◽

Rob Riemsma ◽

Nigel Armstrong ◽

Steve Ryder ◽

...

Keyword(s):

Follicular Lymphoma ◽

Marginal Zone ◽

Evidence Review Group ◽

Marginal Zone Lymphoma ◽

Technology Appraisal ◽

Review Group ◽

Previously Treated ◽

Comment on: “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal”

PharmacoEconomics ◽

10.1007/s40273-017-0502-8 ◽

2017 ◽

Vol 35 (6) ◽

pp. 661-663 ◽

Cited By ~ 1

Author(s):

Odette Reifsnider ◽

Fiona Hall ◽

Sonja Sorensen ◽

Irina Proskorovsky ◽

Isabelle Girod ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Abiraterone Acetate ◽

Technology Appraisal ◽

Castration Resistant Prostate Cancer ◽

Review Group ◽

Castration Resistant ◽

Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-016-0445-5 ◽

2016 ◽

Vol 35 (2) ◽

pp. 191-202 ◽

Cited By ~ 7

Author(s):

Bram L. T. Ramaekers ◽

Rob Riemsma ◽

Florian Tomini ◽

Thea van Asselt ◽

Sohan Deshpande ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Abiraterone Acetate ◽

Technology Appraisal ◽

Castration Resistant Prostate Cancer ◽

Review Group ◽

Castration Resistant ◽

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-017-0581-6 ◽

2017 ◽

Vol 36 (2) ◽

pp. 145-159 ◽

Cited By ~ 6

Author(s):

Nasuh C. Büyükkaramikli ◽

Saskia de Groot ◽

Debra Fayter ◽

Robert Wolff ◽

Nigel Armstrong ◽

...

Keyword(s):

Multiple Myeloma ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Refractory Multiple Myeloma ◽

Previously Treated ◽

Trifluridine–Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-017-0591-4 ◽

2017 ◽

Vol 36 (3) ◽

pp. 285-288 ◽

Cited By ~ 2

Author(s):

Bram L. T. Ramaekers ◽

Robert Wolff ◽

Anoukh van Giessen ◽

Xavier Pouwels ◽

Debra Fayter ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Previously Treated ◽